Records 1-15 (of 15 Records) |
Query Trace: VIP[original query] |
---|
Optimal resource allocation model for COVID-19: a systematic review and meta-analysis. Wang Yu-Yuan, et al. BMC infectious diseases 2024 0 0. (1) 200 |
Advances in wastewater analysis revealing the co-circulating viral trends of noroviruses and omicron subvariants. Kumblathan Teresa, et al. The Science of the total environment 2024 0 0. 170887 |
The accuracy of artificial intelligence in predicting COVID-19 patient mortality: a systematic review and meta-analysis. Xin Yu, et al. BMC medical informatics and decision making 2023 0 0. (1) 155 |
Bioinformatics and systems biology approaches to identify the effects of COVID-19 on neurodegenerative diseases: A review. Bu Fan, et al. Medicine 2023 0 0. (49) e32100 |
Metabolomics-based investigation of SARS-CoV-2 vaccination (Sinovac) reveals an immune-dependent metabolite biomarker. He Maozhang, et al. Frontiers in immunology 2022 0 0. 954801 |
An Artificial Intelligence-guided signature reveals the shared host immune response in MIS-C and Kawasaki disease P Ghosh et al, Nature Comms, May 2022
We compare the two syndromes using a computational toolbox of two gene signatures that were developed in the context of SARS-CoV-2 infection, i.e., the viral pandemic (ViP) and severe-ViP signatures and a 13-transcript signature previously demonstrated to be diagnostic for KD, and validated our findings in whole blood RNA sequences, serum cytokines, and formalin fixed heart tissues. Results show that KD and MIS-C are on the same continuum of the host immune response as COVID-19. Both the pediatric syndromes converge upon an IL15/IL15RA-centric cytokine storm, suggestive of shared proximal pathways of immunopathogenesis
|
A Meta-Analysis of Accuracy and Sensitivity of CRISPR and Chest CT in COVID‑19 Diagnosis Gao, Chun et al. Research Square February 25 2022 |
Lung directed antibody gene transfer confers protection against SARS-CoV-2 infection. Du Yue, et al. Thorax 2022 0 0. |
Clinical efficacy and safety of Qingshu Yiqi decoction as a complementary and alternative therapy for COVID-19 with Delta variant: A protocol for systematic review and meta-analysis. Xia Yu, et al. Medicine 2021 0 0. (50) e28184 |
COVID-19 lung disease shares driver AT2 cytopathic features with Idiopathic pulmonary fibrosis Sinha, Saptarshi et al. bioRxiv November 30 2021 |
AI-guided discovery of the invariant host response to viral pandemics. Sahoo Debashis et al. EBioMedicine 2021 6 103390
Over 45,000 transcriptomic datasets of viral pandemics were analyzed to extract a 166-gene signature using ACE2 as a ?seed? gene; ACE2 was rationalized because it encodes the receptor that facilitates the entry of SARS-CoV-2 (the virus that causes COVID-19) into host cells. An AI-based approach was used to explore the utility of the signature. The 166-gene signature was conserved across all viral pandemics, including COVID-19, and a subset of 20-genes classified disease severity.
|
An AI-guided invariant signature places MIS-C with Kawasaki disease in a continuum of host immune responses. Sahoo Debashis, et al. bioRxiv : the preprint server for biology 2021 0 0. |
[Study on medication regularity of traditional Chinese medicine in treatment of COVID-19 based on data mining]. Zhou Zheng, et al. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 2020 0 0. (6) 1248-1252 |
CT imaging features of 4121 patients with COVID-19: A meta-analysis. Zhu Jieyun, et al. Journal of medical virology 2020 0 0. (7) 891-902 |
AI-guided discovery of the invariant host response to viral pandemics. Sahoo Debashis, et al. bioRxiv : the preprint server for biology 2020 9 0. |
Disclaimer: Articles listed in the Public Health
Knowledge Base are selected by the CDC Office of Public Health
Genomics to provide current awareness of the literature and news.
Inclusion in the update does not necessarily represent the views of
the Centers for Disease Control and Prevention nor does it imply
endorsement of the article's methods or findings. CDC and DHHS assume
no responsibility for the factual accuracy of the items presented. The
selection, omission, or content of items does not imply any
endorsement or other position taken by CDC or DHHS. Opinion, findings
and conclusions expressed by the original authors of items included in
the update, or persons quoted therein, are strictly their own and are
in no way meant to represent the opinion or views of CDC or DHHS.
References to publications, news sources, and non-CDC Websites are
provided solely for informational purposes and do not imply
endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 23, 2024
- Content source: